Project Title

Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery.

A Phase 3, Prospective, Multicenter Study to Evaluate Efficacy and Safety of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Elective Surgical Procedures in Subjects With Severe Von Willebrand Disease.

Project Summary

The purpose of the study is to assess the efficacy and safety of recombinant von Willebrand factor (rVWF) with or without ADVATE in major and minor elective surgical procedures in adult patients with hereditary severe von Willebrand disease (VWD).

Blood Disorder

• Von Willebrand Disease

Patient Recruitment Details

Patient recruitment status: Closed

Number of Patients (globally)

24 participants.

Back to Archived Projects...